The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_000162.5(GCK):c.464G>C (p.Arg155Thr)

CA367401902

447401 (ClinVar)

Gene: GCK
Condition: monogenic diabetes
Inheritance Mode: Semidominant inheritance
UUID: 67f52845-249a-4f84-ab2a-1dc4286da221
Approved on: 2024-04-19
Published on: 2024-04-19

HGVS expressions

NM_000162.5:c.464G>C
NM_000162.5(GCK):c.464G>C (p.Arg155Thr)
NC_000007.14:g.44150975C>G
CM000669.2:g.44150975C>G
NC_000007.13:g.44190574C>G
CM000669.1:g.44190574C>G
NC_000007.12:g.44157099C>G
NG_008847.1:g.43449G>C
NG_008847.2:g.52196G>C
ENST00000395796.8:c.*462G>C
ENST00000616242.5:c.464G>C
ENST00000682635.1:n.950G>C
ENST00000345378.7:c.467G>C
ENST00000403799.8:c.464G>C
ENST00000671824.1:c.464G>C
ENST00000673284.1:c.464G>C
ENST00000345378.6:c.467G>C
ENST00000395796.7:c.461G>C
ENST00000403799.7:c.464G>C
ENST00000437084.1:c.413G>C
ENST00000616242.4:c.461G>C
NM_000162.3:c.464G>C
NM_033507.1:c.467G>C
NM_033508.1:c.461G>C
NM_000162.4:c.464G>C
NM_001354800.1:c.464G>C
NM_033507.2:c.467G>C
NM_033508.2:c.461G>C
NM_033507.3:c.467G>C
NM_033508.3:c.461G>C

Likely Pathogenic

Met criteria codes 5
PM5_Supporting PP4_Moderate PM2_Supporting PP3 PP2
Not Met criteria codes 1
PS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Monogenic Diabetes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GCK Version 1.3.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.464G>C variant in the glucokinase gene, GCK, causes an amino acid change of arginine to threonine at codon 155 (p.(Arg155Thr)) of NM_000162.5. GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2). This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.814, which is greater than the MDEP VCEP threshold of 0.70 (PP3). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). Another missense variant, c.465G>T p.(Arg155Ser), has been classified as likely pathogenic by the ClinGen MDEP (PM5_Supporting). This variant was identified in an individual with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6% and antibody negative ) (PP4_Moderate; PMID: 19410318). This variant was identified in two unrelated individuals with hyperglycemia; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (PMID:19410318​, ClinVar). In summary, c.464G>C meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3.0, approved 8/11/2023): PM2_Supporting, PM5_Supporting, PP3, PP2, PP4_Moderate.
Met criteria codes
PM5_Supporting
Another missense variant, c.465G>T p.(Arg155Ser), has been classified as likely pathogenic by the ClinGen MDEP (PM5_Supporting).
PP4_Moderate
This variant was identified in an individual with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6% and antibody negative ) (PP4_Moderate; PMID: 19410318).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
PP3
This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.814​, which is greater than the MDEP VCEP threshold of 0.70 (PP3).
PP2
GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2).
Not Met criteria codes
PS4
This variant was identified in two unrelated individuals with hyperglycemia; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (PMID:19410318​, ClinVar).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.